NO162469C - Analogifremgangsmaate for fremstilling av terapeutisk aktive purin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive purin-derivater.

Info

Publication number
NO162469C
NO162469C NO832842A NO832842A NO162469C NO 162469 C NO162469 C NO 162469C NO 832842 A NO832842 A NO 832842A NO 832842 A NO832842 A NO 832842A NO 162469 C NO162469 C NO 162469C
Authority
NO
Norway
Prior art keywords
sup
carbon atoms
hydrogen
preparation
therapeutic active
Prior art date
Application number
NO832842A
Other languages
English (en)
Other versions
NO162469B (no
NO832842L (no
Inventor
Julien Pierre Henri Verheyden
John Charles Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO832842L publication Critical patent/NO832842L/no
Publication of NO162469B publication Critical patent/NO162469B/no
Publication of NO162469C publication Critical patent/NO162469C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO832842A 1982-08-09 1983-08-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive purin-derivater. NO162469C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/406,583 US4556659A (en) 1982-08-09 1982-08-09 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents

Publications (3)

Publication Number Publication Date
NO832842L NO832842L (no) 1984-02-10
NO162469B NO162469B (no) 1989-09-25
NO162469C true NO162469C (no) 1990-01-10

Family

ID=23608623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832842A NO162469C (no) 1982-08-09 1983-08-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive purin-derivater.

Country Status (15)

Country Link
US (1) US4556659A (no)
EP (1) EP0105135B1 (no)
JP (1) JPS5948483A (no)
KR (1) KR890000811B1 (no)
AT (1) ATE25980T1 (no)
AU (1) AU571451B2 (no)
DE (1) DE3370331D1 (no)
DK (1) DK361383A (no)
ES (2) ES8603185A1 (no)
FI (1) FI74006C (no)
HU (1) HU193530B (no)
IE (1) IE55843B1 (no)
NO (1) NO162469C (no)
NZ (1) NZ205171A (no)
ZA (1) ZA835799B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US4609661A (en) * 1982-08-09 1986-09-02 Syntex (U.S.A.) Inc. Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents
ZW22283A1 (en) * 1982-10-14 1985-05-22 Wellcome Found Antiviral compounds
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
DE4002792A1 (de) * 1990-01-31 1991-08-01 Teves Gmbh Alfred Vorrichtung zur ermittlung der beschaffenheit einer druckuebertragungsfluessigkeit
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CN110026212B (zh) * 2019-05-23 2022-03-04 临海市利民化工有限公司 一种裂解催化剂及使用该催化剂制备西他沙星中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
CS594082A2 (en) * 1981-08-11 1989-08-14 Wellcome Found Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
FI74006B (fi) 1987-08-31
AU1768383A (en) 1984-02-16
HU193530B (en) 1987-10-28
ES545261A0 (es) 1986-01-01
NO162469B (no) 1989-09-25
ES8603186A1 (es) 1986-01-01
ES524811A0 (es) 1986-01-01
DK361383D0 (da) 1983-08-08
NZ205171A (en) 1987-05-29
FI832832A0 (fi) 1983-08-08
ES8603185A1 (es) 1986-01-01
JPS5948483A (ja) 1984-03-19
KR890000811B1 (ko) 1989-04-08
EP0105135B1 (en) 1987-03-18
DK361383A (da) 1984-02-10
DE3370331D1 (en) 1987-04-23
IE55843B1 (en) 1991-01-30
EP0105135A1 (en) 1984-04-11
KR840006007A (ko) 1984-11-21
ZA835799B (en) 1984-04-25
FI832832A (fi) 1984-02-10
US4556659A (en) 1985-12-03
AU571451B2 (en) 1988-04-21
FI74006C (fi) 1987-12-10
IE831867L (en) 1984-02-09
ATE25980T1 (de) 1987-04-15
NO832842L (no) 1984-02-10

Similar Documents

Publication Publication Date Title
ES8504194A1 (es) Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos.
OA07491A (fr) Nouveaux dérivés de la thiéno (3,2,-c) pyridine, leur procédé de préparation et leur application thérapeutique.
NO162469C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive purin-derivater.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
ES2000346A6 (es) Un procedimiento para la preparacion de derivados de distamicina
SE8302694D0 (sv) Immunomodulating agent
GR3001879T3 (en) Cytoprotective derivatives useful in ischemic diseases, their preparation and compositions containing them
HUT35238A (en) Process for producing diacyloxy-naphtalene derivatives of antipsoriatic activity and pharmaceutical compositions containing them as active agents
ES8501416A1 (es) 5'-alquil o alquenil-fosfatos de nucleosidos.
ES8206551A1 (es) Un procedimiento para la preparacion de derivados de adeno- sina
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
DE69016894D1 (de) Arylpyrazol-Derivate als Plättchenaggregationshemmstoffe.
AR246971A1 (es) Procedimiento para la preparacion de heteroalquilen quinolinaminas fusionadas.
ES8302008A1 (es) Un procedimiento para la preparacion de derivados de imidazo (2,1-b) tiazol.